Back

Impact of GLP-1 receptor agonists on risk of stroke in patients with atrial fibrillation: a Danish nationwide cohort study

29 August 2026 (12:00 - 12:10)
Organised by: Logo
Congress Presentation Part of: Stroke in atrial fibrillation Stroke in Atrial Fibrillation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Maria Pham

Hvidovre Hospital, Copenhagen (Denmark)

5 More presentations in this session

Presentation thumbnail
Improving long-term outcomes in atrial fibrillation: temporal decline in stroke and dementia risk among Danish patients – a nationwide registry-based study
Doctor C. Middelfart (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Ischemic stroke in patients with cancer: impact of atrial fibrillation in a nationwide register-based study
Doctor A. Karagianni (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Competing risks of ischaemic stroke and intracranial haemorrhage in untreated new-onset atrial fibrillation: a nationwide study
Mr A. Luojus (Helsinki, FI)
Abstract Slides Video
Presentation thumbnail
Genetic risk-enhanced CHA₂DS₂-VASc score predicts ischemic stroke after atrial fibrillation catheter ablation
Doctor J. Park (Yongin, KR)
Abstract Slides Video
Presentation thumbnail
Sex- and age-specific risk of ischemic stroke in patients with atrial fibrillation and cancer: a nationwide register-based study
Doctor A. Karagianni (Gothenburg, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Stroke in atrial fibrillation
Video

The Event

Event poster

ESC Congress 2026

29 August 2026 12:00 CET
You may be interested in
thumbnail
Congress Session
What's new for GLP-1 agonist and SGLT2 inhibitor cardiovascular pharmacotherapy?
29 August 2025
thumbnail
Congress Presentation
Stroke rates in non-anticoagulated individuals with and without atrial fibrillation and one non-sex CHA2DS2-VASc risk factor: a nationwide registry-based cohort (Atrial Fibrillation in Norway - AFNOR)
27 August 2022
thumbnail
Congress Presentation
Effect of glucagon-like peptide-1 receptor agonists on atrial fibrillation incidence: a systematic review and meta-analysis
31 August 2025
thumbnail
Congress Presentation
GLP-1 receptor agonist use and clinical outcomes after atrial fibrillation ablation: a 110-center real-world analysis
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources